1. The effect of acyl chain length and saturation on the interactions of pirarubicin with phosphatidylethanolamines in 2D model urothelial cancer cell membranes
   Dorota Matyszewska et al, 2021, Journal of Molecular Liquids CrossRef
2. Comparison of the Efficacy of Postoperative Gemcitabine versus Pirarubicin Perfusion Chemotherapy for Non-Muscle Invasive Bladder Cancer
   文杰 万, 2023, Advances in Clinical Medicine CrossRef
3. Capsaicinoids enhance chemosensitivity to chemotherapeutic drugs
   Jamie R. Friedman et al, 2019, CrossRef
4. Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
   O.A. El-Kawy et al, 2022, Applied Radiation and Isotopes CrossRef
5. Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
   Jianglei Zhang et al, 2021, Journal of Healthcare Engineering CrossRef
6. Capsaicin enhances anti-proliferation efficacy of pirarubicin via activating TRPV1 and inhibiting PCNA nuclear translocation in 5637 cells
   LONG ZHENG et al, 2016, Molecular Medicine Reports CrossRef
7. Homologous Targeting and Adhesion Abilities of Cellular Microvesicles for Enhanced Intravesical Therapy of Bladder Cancer
   Fan Qi et al, 2024, Advanced Therapeutics CrossRef
8. Anaphylactic shock due to intravesical administration of pirarubicin hydrochloride for the fifth time
   Koji Sakata et al, 2016, Journal of Clinical Anesthesia CrossRef
9. Safety Assessment of Ultrasound-Assisted Intravesical Chemotherapy in Normal Dogs: A Pilot Study
   Noboru Sasaki et al, 2022, Frontiers in Pharmacology CrossRef